medical cannabis
medical cannabis · page 51
- Your #1 Podcast on Cannabis News
Understanding the UK and European medical cannabis markets
On this episode of BofC Live, we connect with Dean Friday, CEO and Jonathan Nadler, Group Managing Director of LYPHE Group.
- Companies
LYPHE Group announces revolutionary medical cannabis advisory board
The board will be chaired by Europe’s foremost medical cannabis expert Professor Mike Barnes.
- Cultivation
CANNPRISMA receives Portuguese medical cannabis licence
The authorisation followed an on-site inspection by both PSP and INFARMED.
- CBD Market
180 Life Sciences selects CBD analogue for clinical development
The compound was selected based on a wide-ranging screen of derivatives of CBD and CBG made by cannabis pioneer Professor Mechoulam.
- Medical
Second medical cannabis flower launched by Curaleaf for UK market
Curaleaf aims to improve access and affordability for UK patients with its new products.
- Cultivation
Hellenic Dynamics on track to be first medical cannabis cultivator on LSE
UK SPAC has submitted a first draft of the prospectus to the FCA and has made an application in respect of a Standard Listing.
- CBD Market
UK’s Quantum Farma to provide new cannabis treatments to Latin America
UK company Quantum Farma is working with FarmaUSA to launch two new cannabis treatments in the Latin American market.
- Medical
Panaxia agreement to bring medical cannabis products into Germany
The products are currently being used in Israel for oncology patients for cancer pain, loss of appetite and other side effects related to cancer treatments.
- Medical
A new frontier in medicine: MGC Pharma discusses drug delivery innovation
MGC Pharma is hoping to bring more surprises to the market in the next few years.
- Pharmaceutical
Oxford Cannabinoid Technologies secures drug development agreements
The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May this year.
- Medical
Supply chains urged to use authentication to protect cannabis products
The IHMA says counterfeit cannabis is an alarming development that sees criminals taking advantage of people in desperate need of products.
- Medical
Patent for THC as Alzheimer’s treatment granted to India Globalization
India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer’s disease by 2030
